Nicotinamide Riboside for Arterial Stiffness and High Blood Pressure in Kidney Disease
Phase 2
118
about 4.8 years
35–80
1 site in CO
What this study is about
Researchers are testing whether nicotinamide riboside can help reduce arterial stiffness and high blood pressure in people with kidney disease. The trial will give participants either nicotinamide riboside or a placebo (inactive pill) for 3 months. Researchers will measure the stiffness of their arteries, blood pressure, and levels of certain substances related to inflammation and oxidative stress.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nicotinamide riboside
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: carotid-femoral pulse wave velocity
Secondary: Systolic blood pressure
Renal